BROWSE ALL ARTICLES BY TOPIC
Articles by Keyword - Quality
Listing articles 1 to 10 of 43
From the College: 2014 Physician Quality Reporting System; Important Dates, Deadlines
PQRS reporting deadlines required to meet to reap incentives, avoid penalties
From the College: What Rheumatologists Need to Know about Modifications to the Physician Quality Reporting System in 2014
Changes include modifying claims reporting mechanism as it relates to the rheumatoid arthritis measures group
Patient survey questionnaires, metrics to gauge physician performance may not be trustworthy indicators of quality of patient care
Rising healthcare costs, shifting market forces will require rheumatologists to adapt new quality measurement techniques, more effective patient care models, better rheumatology registries
Rapid change and increasing costs in healthcare have sparked renewed interest in providing high-quality care, but demonstrating quality is difficult
ACR identifies five practices, therapies, or procedures physicians and patients should question
On February 21, the ACR--along with 16 other national medical societies--released its list of Five Things Patients and Physicians Should Question in Rheumatology.
The implementation of a bundle of quality measures for rheumatoid arthritis (RA) helped identify gaps in care delivery, and another quality improvement study resulted in increased safety of intravenous infusions at a pediatric rheumatology practice. These abstracts were among six presented at a session titled, “Quality Measures and Innovations in Practice Management and Care Delivery I,” here at the 2011 ACR/ARHP Annual Scientific Meeting in Chicago in November.
Departments: Ethics Forum: Letters from our Readers
We received several letters in response to the September 2011 “Ethics Forum,” which asked about the proper way to adopt ultrasound in your practice. We thank our respondents for their thoughtful and provocative comments. As many of you are aware, the ACR is currently drafting guidance for the use of musculoskeletal ultrasound. Perhaps we will rethink this topic once these are available.
Rheumatology caught the attention of the broader medical community with an article in the Journal of the American Medical Association showing that only 63% of rheumatoid arthritis (RA) patients in Medicare Advantage programs received disease-modifying antirheumatic drugs (DMARDs) from 2005 to 2008. Lower than the overall DMARD use rates reported by the National Center for Quality Assurance in 2008, which range from 70% for Medicare plans to 85% for commercial plans, a treatment gap is apparent for RA...